Exploring the Past and Current Landscape of Biomarker-Driven Clinical Trials Through Large Language Models First, we pretrained the encoder of a transformer-based network using a self-supervised ...
Semin Liver Dis. 2013;33(3):236-247. Focal nodular hyperplasia has no malignant potential and usually remains stable or decreases in size over time. Less than 20% of patients with FNH develop symptoms ...
SHREVEPORT, La. - Patients diagnosed with liver cancer in the ArkLaTex now have access to a new treatment option closer to ...
An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin.
Researchers at Institute of Science Tokyo created a mouse model of the aggressive subtype of HCC and provided insights into its underlying molecular mechanism. Using these insights, they demonstrated ...
The liver is often called a "silent organ," as it can sustain significant damage without obvious symptoms. But when injury is prolonged, whether from alcohol, poor diet, or chronic hepatitis virus ...
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting ...
UAB Medicine offers liver transplantation as a treatment for metastatic colorectal cancer, expanding access to advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results